Diagnostyka (FRA:7JS) Beginning Cash Position: €4.3 Mil (As of Mar. 2026)


FRA:7JS Diagnostyka SA FRA:7JS
19 GF Score
Price €41.36
! 1 Warning Sign
View Full Analysis

What is Diagnostyka Beginning Cash Position?

Diagnostyka FRA:7JS +1.17% 19 Beginning Cash Position is €4.3 Mil as of Mar. 2026. GuruFocus rates FRA:7JS with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Diagnostyka's Beginning Cash Position for the quarter that ended in Mar. 2026 was €4.3 Mil.

Diagnostyka's quarterly Beginning Cash Position declined from Sep. 2025 (€9.5 Mil) to Dec. 2025 (€7.9 Mil) and declined from Dec. 2025 (€7.9 Mil) to Mar. 2026 (€4.3 Mil).

Diagnostyka's annual Beginning Cash Position increased from Dec. 2023 (€21.1 Mil) to Dec. 2024 (€22.5 Mil) but then declined from Dec. 2024 (€22.5 Mil) to Dec. 2025 (€9.4 Mil).


Diagnostyka Beginning Cash Position Related Terms


Diagnostyka Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Diagnostyka's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostyka Beginning Cash Position Chart

Diagnostyka Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
35.91 38.08 21.05 22.51 9.37

Diagnostyka Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.37 7.74 9.53 7.89 4.26
FRA:7JS
19GF Score
Diagnostyka SA FRA:7JS
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostyka Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €4.3 Mil mean?
Diagnostyka (FRA:7JS) has a Beginning Cash Position of €4.3 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Diagnostyka and its competitors.
Is Diagnostyka's Beginning Cash Position too high?
Diagnostyka's current Beginning Cash Position is €4.3 Mil. Overall, Diagnostyka has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's Beginning Cash Position compare to TMO and DHR?
Diagnostyka's Beginning Cash Position of €4.3 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Diagnostyka and its competitors. Diagnostyka's current Beginning Cash Position is €4.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current Beginning Cash Position of €4.3 Mil. The current Beginning Cash Position is €4.3 Mil. Diagnostyka's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current Beginning Cash Position is €4.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnostyka Business Description

Other Exchanges DIA:Poland
Address Ul. Prof. Michala Zyczkowskiego 16, Krakow, POL, 31-864
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
19GF Score

Get the complete analysis for FRA:7JS

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.36
Price